Trademark: 79326492
Word
NERPHARMA PART OF NMS GROUP
Status Date
Tuesday, February 21, 2023
Registration Number
6982503
Registration Date
Tuesday, February 21, 2023
Filing Date
Friday, July 9, 2021
Published for Opposition
Tuesday, December 6, 2022
41 Education, namely, providing classes, courses, seminars, workshops, related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; providing of training related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; providing entertainment in the nature of exhibitions, live shows, video and films, related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; know-how transfer training related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; providing online electronic publications, not downloadable, related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; publication of texts, other than publicity texts, related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; arranging and conducting of conferences, congresses and symposium in the medical and pharmaceutical fields
5 Pharmaceutical and veterinary preparations for treating cancer, myocardium infarction and malaria; sanitary preparations for medical purposes; biological preparations for medical purposes, namely, for the treatment of cancer, myocardium infarction and malaria; chemical preparations for pharmaceutical purposes, namely, for treating cancer, myocardium infarction and malaria; chemico-pharmaceutical preparations for treating disease, namely, treating cancer, myocardium infarction and malaria; diagnostic preparations for medical purposes; pharmaceutical preparations for treating cancer, myocardium infarction and malaria
42 Scientific, technological, analysis and research services, namely, research and development in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; biological research in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; chemical research in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; clinical trials in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; quality control in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; scientific laboratory services
Jun 12, 2023
Final Decision Transaction Processed By Ib
May 24, 2023
Final Disposition Notice Sent To Ib
May 24, 2023
Final Disposition Processed
May 21, 2023
Final Disposition Notice Created, To Be Sent To Ib
Feb 21, 2023
Notice Of Registration Confirmation Emailed
Feb 21, 2023
Registered-Principal Register
Dec 12, 2022
Notification Processed By Ib
Dec 6, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 6, 2022
Published For Opposition
Nov 23, 2022
Notification Of Possible Opposition Sent To Ib
Nov 23, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 16, 2022
Notification Of Notice Of Publication E-Mailed
Oct 30, 2022
Approved For Pub - Principal Register
Sep 17, 2022
Teas/Email Correspondence Entered
Sep 16, 2022
Correspondence Received In Law Office
Sep 16, 2022
Teas Response To Office Action Received
Sep 12, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 12, 2022
Teas Change Of Correspondence Received
Sep 12, 2022
Teas Change Of Domestic Representatives Address
Sep 12, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 12, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 12, 2022
Teas Change Of Owner Address Received
Jun 7, 2022
Refusal Processed By Ib
May 19, 2022
Non-Final Action Mailed - Refusal Sent To Ib
May 19, 2022
Refusal Processed By Mpu
Apr 8, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Apr 7, 2022
Non-Final Action Written
Mar 29, 2022
Assigned To Examiner
Nov 30, 2021
Application Filing Receipt Mailed
Nov 26, 2021
New Application Office Supplied Data Entered
Nov 25, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
